Eli Lilly and Company

Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week

Eli Lilly's obesity pill Foundayo recorded 1,390 U.S. prescriptions in its debut week, trailing Novo Nordisk's oral Wegovy. Launch data underscores intensifying competition in the oral obesity drug ma